Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues |
| Research & Development Solutions | 1,950.0 | 1,934.0 | 1,944.0 | 1,853.0 | 1,891.0 | 1,868.0 | 1,684.0 | 1,400.0 |
| Technology & Analytics Solutions | 1,408.0 | 1,439.0 | 1,496.0 | 1,337.0 | 1,353.0 | 1,348.0 | 1,425.0 | 1,207.0 |
| Contract Sales & Medical Solutions | 183.0 | 195.0 | 196.0 | 201.0 | 194.0 | 193.0 | 189.0 | 179.0 |
| |
| EBITDA |
| |
| EBIT |
| |
| Mix |
| Research & Development Solutions | 55.1% | 54.2% | 53.5% | 54.6% | 55.0% | 54.8% | 51.1% | 50.3% |
| Technology & Analytics Solutions | 39.8% | 40.3% | 41.1% | 39.4% | 39.4% | 39.5% | 43.2% | 43.3% |
| Contract Sales & Medical Solutions | 5.2% | 5.5% | 5.4% | 5.9% | 5.6% | 5.7% | 5.7% | 6.4% |
| |
| Growth |
| Research & Development Solutions | 3.1% | 3.5% | 15.4% | 32.4% | 53.1% | 29.6% | 14.5% | -4.5% |
| Technology & Analytics Solutions | 4.1% | 6.8% | 5.0% | 10.8% | 22.0% | 20.7% | 17.4% | 10.2% |
| Contract Sales & Medical Solutions | -5.7% | 1.0% | 3.7% | 12.3% | 9.6% | -1.5% | -10.0% | -13.9% |
|